Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The use of a new generation low molecular weight heparin (Bemiparin)and the well known LMWH
(Enoxaparin) after Caesarean sections and vaginal deliveries in a risky group patients for
venous thrombosis.